Sichuan Kelun-biotech Biopharmaceutical Co., Ltd.

This study tests a new experimental drug called SKB518 in 150 adults with advanced solid tumors that have stopped responding to standard treatments or have no effective therapy. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. Pa…

This early-phase trial is testing a new drug called SKB107 in people with advanced solid tumors that have spread to the bone. The main goals are to check the drug's safety and how the body processes it. About 90 adults aged 18-75 who have exhausted standard treatments may join. T…

This study tests a new drug called SKB264 against standard chemotherapy in people with advanced HR+/HER2- breast cancer that has not responded to at least one prior chemotherapy. The goal is to see if SKB264 can slow cancer growth or improve survival. About 376 adults aged 18-75 …

This early-stage study tests a new medicine called SKB575 in 90 people, first in healthy volunteers and then in those with moderate-to-severe atopic dermatitis (eczema). The main goals are to check safety and see if it can reduce eczema symptoms like redness and itching. Particip…